MBIO - MUSTANG BIO, INC.
0.8963
-0.053 -5.913%
Share volume: 41,407
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.95
-0.05
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-13-2024 | 11-08-2024 | 03-28-2025 | 05-14-2025 | 08-08-2025 | 11-07-2025 | |
| Assets | ||||||||
| Total Assets | 14.592 M | 8.519 M | 7.193 M | 9.308 M | 14.909 M | 13.046 M | 19.361 M | |
| Current Assets | 9.240 M | 7.319 M | 6.055 M | 8.606 M | 14.909 M | 13.046 M | 19.361 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 2.209 M | 2.209 M | 1.165 M | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.337 M | 4.268 M | 3.525 M | 6.839 M | 14.231 M | 12.657 M | 18.984 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.962 M | 472.000 K | 421.000 K | 371.000 K | 0.000 | 0.000 | 0.000 | |
| Other Assets | 2.390 M | 728.000 K | 717.000 K | 331.000 K | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 14.592 M | 8.519 M | 7.193 M | 9.308 M | 14.909 M | 13.046 M | 19.361 M | |
| Total liabilities | 19.535 M | 16.849 M | 15.849 M | 13.181 M | 11.300 M | 10.154 M | 9.590 M | |
| Total current liabilities | 17.438 M | 15.923 M | 15.038 M | 12.609 M | 11.150 M | 10.004 M | 9.440 M | |
| Accounts Payable | 15.014 M | 13.190 M | 12.061 M | 9.486 M | 8.337 M | 7.500 M | 6.911 M | |
| Other liabilities | 2.097 M | 926.000 K | 541.000 K | 572.000 K | 150.000 K | 150.000 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.097 M | 926.000 K | 541.000 K | 572.000 K | 150.000 K | 150.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -4.943 M | -8.330 M | -8.656 M | -3.873 M | 3.609 M | 2.892 M | 9.771 M | |
| Common stock | 381.219 M | 386.031 M | 387.115 M | 392.850 M | 400.485 M | 400.530 M | 407.877 M | |
| Retained earnings | -386.162 M | -394.361 M | -395.771 M | -396.723 M | -396.876 M | -397.638 M | -398.106 M |